Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Fant

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
American Journal of Hospital Pharmacy|March 1, 1986
Controversies in antimicrobial therapy: pitfalls in monitoring aminoglycoside therapyW K Fant
Pharmacoeconomics|May 8, 1993
Novel monoclonal antiendotoxin antibody therapy: efficacy at any price?W K Fant
American Journal of Hospital Pharmacy|November 1, 1990
Selecting patients for monoclonal antibody therapyW K Fant
Drug Intelligence & Clinical Pharmacy|September 1, 1988
Cefuroxime axetilM A Marx, W K Fant
Hospital Pharmacy|July 9, 1985
Cost-effectiveness analysis as a tool to compare two methods of preparing and administering intravenous heparin solutionsM A Oszko, W K Fant
The Journal of Antimicrobial Chemotherapy|November 1, 1991
Increased dosing requirements for amikacin in burned childrenR G Kopcha, W K Fant, G D Warden
American Journal of Hospital Pharmacy|October 1, 1991
Inability to justify a part-time clinical pharmacist in a community hospital intensive-care unitC L Rosenbaum, W K Fant, C I Miyagawa, et al.
The American Journal of Medicine|June 7, 1985
Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infectionsJ S Solomkin, W K Fant, J O Rivera, et al.
Clinical Pharmacokinetics|September 1, 1984
Prediction of steady-state nortriptyline plasma levels by the repeated one-point methodW K Fant, W A Ritschel, S K Alwis, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 1989
The effect of "superactive" charcoal and magnesium citrate solution on blood ethanol concentrations and area under the curve in humansB G Katona, E G Siegel, J R Roberts, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
American Journal of Hospital Pharmacy|March 1, 1986
Controversies in antimicrobial therapy: pitfalls in monitoring aminoglycoside therapyW K Fant
Pharmacoeconomics|May 8, 1993
Novel monoclonal antiendotoxin antibody therapy: efficacy at any price?W K Fant
American Journal of Hospital Pharmacy|November 1, 1990
Selecting patients for monoclonal antibody therapyW K Fant
Drug Intelligence & Clinical Pharmacy|September 1, 1988
Cefuroxime axetilM A Marx, W K Fant
Hospital Pharmacy|July 9, 1985
Cost-effectiveness analysis as a tool to compare two methods of preparing and administering intravenous heparin solutionsM A Oszko, W K Fant
The Journal of Antimicrobial Chemotherapy|November 1, 1991
Increased dosing requirements for amikacin in burned childrenR G Kopcha, W K Fant, G D Warden
American Journal of Hospital Pharmacy|October 1, 1991
Inability to justify a part-time clinical pharmacist in a community hospital intensive-care unitC L Rosenbaum, W K Fant, C I Miyagawa, et al.
The American Journal of Medicine|June 7, 1985
Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infectionsJ S Solomkin, W K Fant, J O Rivera, et al.
Clinical Pharmacokinetics|September 1, 1984
Prediction of steady-state nortriptyline plasma levels by the repeated one-point methodW K Fant, W A Ritschel, S K Alwis, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 1989
The effect of "superactive" charcoal and magnesium citrate solution on blood ethanol concentrations and area under the curve in humansB G Katona, E G Siegel, J R Roberts, et al.
Pageof 2